Location: Home
  • search
  • go
  • Relate News
  • 11/6/2024NMPA Accepts AbbVie's BLA for Epcoritamab (Epkinly) for Lymphomas
  • 11/6/2024Shenyang Biotech Secures Pre-A Series Funding to Advance Peptide Vacci...
  • 11/6/2024Novo Nordisk Reports Strong Growth in China for 3Qs of 2024, Driven by...
  • 11/6/2024BioCity Presents Late-Breaking Phase 2 Results for IgA Nephropathy Tre...
  • 11/6/2024Pharma Firms Present Innovative Treatments for Major Diseases at CIIE
  • 11/6/2024Novartis Highlights Commitment to China's Market at CIIE
  • 11/6/2024Innovent Cancels 20% Stake Sale Amid Investor Concerns
  • 11/6/2024MNCs and Chinese Partners Join Forces to Build an Innovative Healthcar...
  • 11/5/2024Aurobindo Challenges China in the Global Penicillin G Market with New ...
  • 11/5/2024NMPA Solicits Public Comments on Drug Contract Manufacturing Document
  • 11/5/2024AstraZeneca China Updates Leadership and Ownership Structure Amid Inve...
  • 11/5/2024Huadong Medicine's Ustekinumab Biosimilar HDM3001 Receives Approval
  • 11/5/2024Photocure's Hexvix Secures Approval in China for Bladder Cancer Diagno...
  • 11/5/2024Landmark Whistleblower Program for China's Healthcare Sector: Proposed...
  • 11/4/2024Probe of AstraZeneca Executive in China Raises Questions about Company...
  • 11/4/2024How AstraZeneca Bilked China's Insurance Program Out of CNY Millions (...
  • 11/4/2024Big Pharma Doubles Down on China (The Wire China)
  • 11/4/2024CARsgen and Galapagos Resume CAR-T Trials Following Regulatory Pauses
  • 11/4/2024HuidaGene Receives the First-Ever FDA Clearance of CRISPR/Cas13 RNA-Ed...
  • 11/4/2024Akeso Announces First Patient Enrollment in Phase 3 Trial of Ivonescim...
  • 11/4/2024Hangzhou Reprogenix Secures Over CNY 100M in Series A Funding, Advanci...
  • 11/4/2024CureGene Completes Series B+ Financing, Advancing Cardiovascular and A...
  • 11/4/2024US FDA Accepts BLA for HLX14, Biosimilar Candidate of PROLIA/XGEVA
  • 11/4/2024NeuroDawn Completes Series C Financing to Advance CNS Drug Pipeline
  • 11/4/2024Saudi FDA Chief Highlights Investment Opportunities for Chinese Cos in...
  • 11/4/2024China Targets AstraZeneca in BMI Fraud Probe over Tagrisso
  • 11/4/2024BIOSECURE Act May Shift Biopharma Manufacturing from China to India, S...
  • 11/4/2024The 10th Round of National Level VBP of Drugs Officially Initiated wit...
  • 11/4/2024NMPA Signs Letter of Intent on Cooperation with Danish Medicines Agenc...
  • 11/4/2024Li Li Meets with Head of Brazil's Health Regulatory Agency
  • Page:28/761 Total number of articles:22828: [First][<<] [26] [27] [28] [29] [30] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group